Rheumatoid Arthritis
Significance of ANA+ in Managing RA: Dr Eric Dein
Dr. Eric Dein reviews abstract #0755 presented at the ACR annual meeting.
4 years ago
Great thoughts-how do we define seronegative RA as well? more studies like this are needed for patient centered medicine! @ACRheum @RheumNow @OSUWexMed #ACR20 https://t.co/7fUO70t09u
HCQ and QTc in RA and SLE Patients: Dr. Kathryn Dao
Dr. Kathryn Dao reviews abstract #0431 presented at the 2020 ACR annual meeting.
4 years ago
Watch my video discussing the SEAM-RA trial of treatment reduction in RA patients in remission on @rheumnow #ACR20 https://t.co/YDfBafBdRs
Lifestyle, Clinical Risk Factors for RA-ILD: Dr. Sheila Reyes
Dr. Sheila Reyes reviews abstract #1198 presented at the 2020 ACR annual meeting.
4 years ago
Factors Associated to Clinical and Radiographic Disease Progression in Patients with Early RA and First-degree Relatives: A 1-year Follow-up https://t.co/GWboXit6m1 #RA #firstdegreerelatives obesity and periodontal disease drive risk - both preventable
4 years ago
So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheumnow), Dr. Arthur Kavanaugh, Dr. Michale Pillinger, and Dr. Bella Mehta! #ACR20
4 years ago
Minimum Clinically Important Improvement in Patients with Rheumatoid Arthritis Associates with Gut Microbiome https://t.co/D3ILR57gXY #RA #microbiome that microbiome again
4 years ago
Time to Discontinuation of Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients with and Without Methotrexate: Real World Results from a Rheumatoid Arthritis Cohort https://t.co/ZzhE0J7dOX #TOFA #TNFi TNFi does better with MTX Tofa less necessary
Impact of Exercise on Sleep in RA: Dr. Kathryn Dao
Dr. Kathryn Dao discusses abstract #0134 presented Friday at the 2020 ACR annual meeting.
Poster Hall